OOIR: Observatory of International Research

Papers

(The H4-Index of Expert Review of Clinical Pharmacology is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence	137
Blinding and expectancy confounds in psychedelic randomized controlled trials	111
Cancer prevention and treatment using combination therapy with natural compounds	87
Contraception and reproductive planning during the COVID-19 pandemic	71
The use of isotretinoin for acne – an update on optimal dosing, surveillance, and adverse effects	57
Pharmacological Management of Postmenopausal Osteoporosis: a Level I Evidence Based - Expert Opinion	48
Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications	42
Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments	39
Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis	38
An update on the clinical pharmacology of methylphenidate: therapeutic efficacy, abuse potential and future considerations	37
The ‘entourage effect’ or ‘hodge-podge hashish’: the questionable rebranding, marketing, and expectations of cannabis polypharmacy	34
Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause	33
Pharmacokinetic/pharmacodynamic target attainment in critically ill renal patients on antimicrobial usage: focus on novel beta-lactams and beta lactams/beta-lactamase inhibitors	31
Molecular docking and dynamics study to explore phytochemical ligand molecules against the main protease of SARS-CoV-2 from extensive phytochemical datasets	30
An update on the complex relationship between clozapine and pneumonia	30
Activation of Nrf2 signaling pathway by natural and synthetic chalcones: a therapeutic road map for oxidative stress	28
Switching biologics in psoriasis - practical guidance and evidence to support	28
Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations	27
Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome	27
Clozapine-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review	26
Prediction of vancomycin dose on high-dimensional data using machine learning techniques	25
Review of galectin-3 inhibitors in the treatment of nonalcoholic steatohepatitis	25
Clinical pharmacology and PK/PD translation of the second-generation Bruton’s tyrosine kinase inhibitor, zanubrutinib	25
The potential role of interventions impacting on gut-microbiota in epilepsy	24